YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,403,777 | $1,523,120 | $1,674,413 | $3,781,609 |
| Short-Term Investments | $3,839 | $0 | $0 | $0 |
| Receivables | $2,155,554 | $1,889,237 | $2,072,611 | $1,113,227 |
| Inventory | $645,929 | $581,153 | $409,050 | $353,545 |
| Other Curr. Assets | $824,304 | $1,514,100 | $1,878,296 | $1,365,529 |
| Total Curr. Assets | $5,033,403 | $5,468,843 | $6,053,056 | $6,613,910 |
| Property Plant & Equip (Net) | $4,607,514 | $3,910,453 | $3,849,668 | $3,560,652 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2,509,760 | $1,373,536 | $2,571,761 | $1,754,827 |
| Long-Term Investments | $38,691 | $25,617 | $32,158 | $12,345 |
| Tax Assets | $236,008 | $0 | $237,686 | $120,066 |
| Other NC Assets | $3,839 | $1,715,747 | $0 | -$120,066 |
| Total NC Assets | $7,395,812 | $7,025,353 | $6,691,273 | $5,327,824 |
| Other Assets | $0 | $0 | $0 | $1,502,462 |
| Total Assets | $12,429,215 | $12,494,196 | $12,744,329 | $13,444,196 |
| Liabilities | – | – | – | – |
| Payables | $177,286 | $458,126 | $200,088 | $185,363 |
| Short-Term Debt | $1,335,029 | $1,233,486 | $2,319,877 | $3,972,586 |
| Tax Payable | $92,934 | $0 | $297,343 | $169,009 |
| Deferred Revenue | $0 | -$170,074 | -$359 | -$3,972,586 |
| Other Curr. Liab. | $1,235,282 | $846,850 | $1,514,912 | $1,330,838 |
| Total Curr. Liab. | $2,840,531 | $2,538,462 | $4,332,220 | $5,657,796 |
| LT Debt | $899,806 | $1,105,806 | $289,451 | $507,083 |
| Deferred Rev, NC | $180,682 | $0 | $0 | $185,392 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $321,691 |
| Other NC Liab. | $0 | $184,548 | $187,145 | $0 |
| Total NC Liab. | $1,080,488 | $1,290,354 | $476,596 | $507,083 |
| Other Liabilities | $0 | $0 | $0 | $185,392 |
| Cap. Leases | $313,864 | $271,166 | $1,524 | $0 |
| Total Liabilities | $3,921,019 | $3,828,816 | $4,808,816 | $6,350,271 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $439,987 | $0 |
| Common Stock | $879,968 | $879,968 | $879,968 | $879,968 |
| Retained Earnings | $4,429,856 | $5,071,862 | $3,947,144 | $3,424,002 |
| AOCI | $0 | $2,713,550 | $2,668,414 | $2,610,409 |
| Other Equity | $3,198,372 | $0 | $0 | $0 |
| Total Equity | $8,508,196 | $8,665,380 | $7,935,513 | $6,914,379 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $179,546 |
| Total Liab. & Tot. Equity | $12,429,215 | $12,494,196 | $12,744,329 | $13,444,196 |
| Net Debt | $831,058 | $816,172 | $934,915 | $698,060 |